Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay

Rheumatology

Volumn 49, Issue 12, 2010, Pages 2370-2374

  Ghirardello, Anna ^a   Rampudda, Mariaelisa ^a   Ekholm, Louise ^b   Bassi, Nicola ^a   Tarricone, Elena ^a   Zampieri, Sandra ^a   Zen, Margherita ^a   Vattemi, Gaetano A ^c   Lundberg, Ingrid E ^b   Doria, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Autoimmune myositis; Diagnostic accuracy; Immunoblot; Immunoprecipitation; Line blot; Myositis specific autoantibodies; Serological methods

Indexed keywords

ANTIGEN; ANTIGEN JO 1; ANTIGEN MI 2; ANTIGEN PL 12; ANTIGEN PL 7; ANTIGEN PM; ANTIGEN RO 52; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; KU ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LINE BLOT ASSAY; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEROLOGY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; IMMUNOBLOTTING; ITALY; MALE; MIDDLE AGED; MYOSITIS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; STATISTICS AS TOPIC; SWEDEN; YOUNG ADULT;

EID: 78549289221     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq281     Document Type: Article

References (20)

1. Love LA, Leff RL, Fraser DD et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360-74.
2. Brouwer R, Hengstmam GJ, Vree Egberts W et al. Autoantibodies profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116-23.
3. Ghirardello A, Zampieri S, Tarricone E et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 2006;39:217-21.
4. Chinoy H, Fertig N, Oddis CV, Ollier WER, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007;66:1345-9.
5. Troyanov Y, Targoff IN, Tremblay JL, Gauler JR, Raymand Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap features and autoantibodies. Medicine 2005;84:231-49.
6. Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. J Bone Spine 2006;73:646-54.
7. Rozman B, Euenik S, Sodin-Semrl S et al. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multicentre case-control study. Ann Rheum Dis 2008;67: 1282-6.
8. Rönnelid J, Barbasso Helmers S, Storfors H et al. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 2009;9:58-61.
9. Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A. Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 2009;8:645-9.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). New Engl J Med 1975;292:344-7.
11. Ghirardello A, Zampieri S, Iaccarino L et al. Anti-Mi-2 antibodies. Autoimmunity 2005;38:79-83.
12. Ghirardello A, Doria A, Vesco P et al. Blotting pattern of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996;16:145-50.
13. Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 2000;59: 875-81.
14. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senecal J-L. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007;9:R78.
15. Doria A, Sarzi-Puttini P, Shoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008;8:1-4.
16. Doria A, Zampieri S, Sarzi-Puttini P. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 2008;8:89-91.
17. Franceschini F, Cavazzana I, Generali D et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 2002; 29:1393-7.
18. Hengstman GJD, Vree Egberts WTM, Seelig HP et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2b antigen. Ann Rheum Dis 2006;65:242-5.
19. Suzuki S, Satoh T, Sato S et al. Clnical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology 2008;47:1539-42.
20. Hengstman GJ, ter Laak HJ, Vree Egberts WT et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 2006;65: 1635-8.